Roger Morgan

A phase 1 clinical trial of the sigma‐2 receptor complex allosteric antagonist CT1812, a novel therapeutic candidate for Alzheimer's disease

Michael Grundman, Roger Morgan, Jason D. Lickliter et al. · Alzheimer s & Dementia Translational Research & Clinical Interventions · 2018 · 106 citations · Full text

Maturation of Sympathetic Neurotransmission in the Rat Heart

D L Bareis, Roger Morgan, Christopher Lau et al. · Developmental Neuroscience · 1981 · 45 citations

Effects of Steady-State Lopinavir/Ritonavir on the Pharmacokinetics of Pitavastatin in Healthy Adult Volunteers

Roger Morgan, Stuart Campbell, Kazuhito Suehira et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2012 · 31 citations

Comparison of the Lipid-Lowering Effects of Pitavastatin 4 mg Versus Pravastatin 40 mg in Adults With Primary Hyperlipidemia or Mixed (Combined) Dyslipidemia: A Phase IV, Prospective, US, Multicenter, Randomized, Double-blind, Superiority Trial

Craig A. Sponseller, Roger Morgan, Vladimir A. Kryzhanovski et al. · Clinical Therapeutics · 2014 · 28 citations

Metabolic Syndrome, Lipid-lowering Effects, Superiority Trial +8

Comparison of the Safety, Tolerability, and Pharmacokinetic Profile of a Single Oral Dose of Pitavastatin 4 mg in Adult Subjects With Severe Renal Impairment Not on Hemodialysis Versus Healthy Adult Subjects

Roger Morgan, Stuart Campbell, Christine Yu et al. · Journal of Cardiovascular Pharmacology · 2012 · 26 citations

Renal Pathology, Dialysis Therapy, Hyperlipidemia +18